- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
MannKind Corp+ Add to Watchlist
MNKD:US4.3700 USD 0.1900 4.55%
As of 20:10:00 ET on 05/04/2015.
Company Profile for MannKind Corp (MNKD)
MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.
Key Executives for MannKind Corp (MNKD)
|Alfred E MannChairman||Hakan S EdstromPresident/CEO|
|Matthew J Pfeffer "Matt"VP/CFO/Investor Relations||Juergen A MartensVP/COO|
|David B ThomsonVP/Secy/General Counsel||Diane M PalumboVP:Human Resources|